BTB-1 is primarily used as a selective inhibitor in biochemical research, particularly targeting specific kinases involved in cellular signaling pathways. It has shown potential in studying inflammation and cancer-related processes due to its ability to modulate key protein activities. Its high selectivity makes it valuable in developing targeted therapies and in validating drug targets during preclinical studies. Researchers also utilize BTB-1 in cellular assays to probe kinase function and to assess the downstream effects of kinase inhibition on cell proliferation and survival.